Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order comments; we will fulfill your request to the best of our ability.
Note: All proteins are shipped with standard blue ice packs unless otherwise specified. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Based on homology with other herpesvirus proteins, OsHV-1 ORF47 is likely a serine/threonine protein kinase. In the well-studied varicella-zoster virus (VZV), the ORF47 protein functions as a serine kinase that phosphorylates regulatory viral proteins . Similar to VZV ORF47, the OsHV-1 ORF47 protein may be involved in phosphorylating viral regulatory proteins critical for viral replication and may be packaged in the tegument of viral particles.
Recombinant OsHV-1 ORF47 protein should theoretically maintain similar structural and functional properties as the native protein, though expression systems may affect post-translational modifications. Studies with recombinant VZV ORF47 have shown that preservation of kinase activity requires specific in vitro conditions, including physiological concentrations of polyamines . Researchers should consider that recombinant OsHV-1 ORF47 may similarly require specific conditions to maintain its biological activity in experimental settings.
To verify kinase activity, researchers should design in vitro kinase assays with purified recombinant OsHV-1 ORF47 protein. Drawing from VZV ORF47 research, assays should include physiological concentrations of polyamines and appropriate substrates . Potential substrates may include OsHV-1 regulatory proteins similar to how VZV ORF47 phosphorylates ORF62 and ORF63 proteins. Researchers should also consider co-immunoprecipitation experiments to identify protein-protein interactions, as VZV ORF47 was found to co-precipitate with ORF63 protein .
Drawing parallels from VZV research, OsHV-1 ORF47 likely plays a critical role in viral pathogenesis within specific host cell types. In VZV, ORF47 is essential for viral replication in human T cells and skin epithelial cells but dispensable in tissue culture . This suggests that OsHV-1 ORF47 may have cell type-specific functions within molluscan hosts, potentially being crucial for infection of certain cells while dispensable in others. Researchers should investigate whether OsHV-1 ORF47 similarly influences tissue tropism by comparing wild-type virus with ORF47-deficient mutants in different oyster cell types.
OsHV-1 ORF47 may be a key virulence determinant in molluscan hosts. VZV studies demonstrate that ORF47 is required for replication in differentiated human cells that are essential targets for pathogenesis in vivo, while being dispensable in vitro . Similarly, OsHV-1 ORF47 might be essential for replication in specific oyster cell types critical for disease progression. Researchers should develop ORF47-deficient OsHV-1 mutants and evaluate their replication capacity in different oyster tissues to determine its role in pathogenesis.
Based on VZV ORF47 studies, potential interaction partners for OsHV-1 ORF47 could include:
Viral regulatory proteins equivalent to VZV ORF62 and ORF63, which are phosphorylated by VZV ORF47
Viral envelope glycoproteins, as VZV ORF47 may phosphorylate glycoprotein E
Host cellular proteins involved in protein synthesis, similar to how HSV-1 UL13 (homolog of VZV ORF47) hyperphosphorylates elongation factor 1δ
Researchers should employ co-immunoprecipitation, yeast two-hybrid systems, or proximity ligation assays to identify these potential interactions.
Based on findings with VZV ORF47, researchers should consider the following conditions:
Inclusion of physiological concentrations of polyamines in enzyme assays
Temperature conditions mimicking the natural host environment of oysters (lower than mammalian 37°C)
Appropriate pH and salt concentrations relevant to mollusk cellular environments
Presence of proper cofactors such as ATP and divalent cations (Mg²⁺, Mn²⁺)
The VZV research demonstrated that "preservation of the intrinsic kinase activity of recombinant VZV ORF47 required unusually stringent in vitro conditions," suggesting that similar considerations may be crucial for OsHV-1 ORF47 .
To study ORF47 function through loss-of-function approaches, researchers should:
Generate ORF47-deficient mutants using techniques similar to those used for VZV, such as inserting stop codons early in the ORF47 coding sequence
Create a complemented strain by inserting the intact ORF47 gene at a distant, non-coding site in the viral genome to verify phenotype specificity
Confirm mutant construction by PCR amplification and sequencing of relevant genomic regions
Verify protein expression patterns using Western blot analysis
Researchers should also develop cell culture systems permissive for OsHV-1 replication to facilitate these genetic studies.
For studying OsHV-1 ORF47 function in vivo, researchers should consider:
Laboratory-controlled infections in susceptible oyster species (Crassostrea gigas)
Infection of specific oyster tissues or primary cell cultures derived from relevant tissues
Development of a system analogous to the SCID-hu mouse model used for VZV, which allowed study of viral replication in human tissue implants
The experimental design should include:
| Experimental Group | Description | Key Measurements |
|---|---|---|
| Wild-type OsHV-1 | Control group | Viral replication kinetics, protein expression, tissue distribution |
| ORF47-deficient OsHV-1 | Test group | Comparative replication capacity, protein expression patterns |
| Complemented ORF47 mutant | Verification group | Restoration of wild-type phenotype |
| Mock-infected | Negative control | Baseline measurements |
Differentiating direct and indirect effects of OsHV-1 ORF47 requires multiple complementary approaches:
In vitro kinase assays with purified components to identify direct phosphorylation targets
Phosphoproteomics comparing wild-type and ORF47-deficient virus-infected cells
Temporal analysis of phosphorylation events during infection
Site-directed mutagenesis of the kinase active site to create catalytically inactive ORF47
Researchers should consider that in VZV, the ORF47 protein enters the cell with the virus as part of the tegument, suggesting immediate early effects distinct from later gene expression effects .
The VZV research provides important insights into potential compensatory mechanisms that could mask OsHV-1 ORF47 functions:
Cellular kinases may compensate for ORF47 function in certain cell types but not others, explaining why VZV ORF47 is dispensable in tissue culture but essential in differentiated human cells
Other viral kinases may partially compensate for ORF47 function, as suggested by the observation that VZV ORF66 (another viral kinase) could not fully compensate for ORF47 deficiency
High levels of cellular casein kinase II (CKII) in cultured cells may compensate for ORF47 absence, as CKII can phosphorylate some of the same substrates
Researchers should design experiments to account for these potential compensatory mechanisms.
Based on the VZV ORF47 research, researchers studying OsHV-1 ORF47 should anticipate potential contradictions between in vitro and in vivo findings . Strategies to address these contradictions include:
Using multiple cell types and culture conditions that better represent the in vivo environment
Developing organotypic culture systems that maintain the differentiated state of mollusk tissues
Performing comprehensive in vivo experiments with appropriate controls
Analyzing gene expression and protein modifications in both settings to identify differences
The VZV research demonstrated that "this gene product, which is dispensable in vitro, has a critical role within differentiated cells that are essential targets for VZV pathogenesis in vivo," highlighting the importance of in vivo verification .
Several cutting-edge technologies could significantly advance OsHV-1 ORF47 research:
CRISPR-Cas9 genome editing for more precise genetic manipulation of OsHV-1
Single-cell transcriptomics and proteomics to understand cell type-specific effects of ORF47
Cryo-electron microscopy for structural determination of ORF47 alone and in complex with substrates
Phosphoproteomics to identify the complete set of ORF47 substrates during infection
Oyster cell and tissue culture systems that better mimic the in vivo environment
These technologies could help overcome current limitations in studying OsHV-1 pathogenesis in molluscan hosts.
Structure-function studies of OsHV-1 ORF47 could lead to the development of specific kinase inhibitors as potential antivirals. Researchers should:
Determine the crystal structure of OsHV-1 ORF47 kinase domain
Identify key catalytic residues through site-directed mutagenesis
Perform in silico screening for potential inhibitors targeting the ATP-binding pocket
Validate candidate inhibitors using in vitro kinase assays and viral replication studies
The essential nature of ORF47 for VZV replication in specific cell types suggests that targeting its OsHV-1 homolog could be an effective antiviral strategy for protecting oyster populations .
OsHV-1 ORF47 research could provide valuable insights into herpesvirus evolution across different host species:
Comparative analysis of protein kinase conservation between vertebrate and invertebrate herpesviruses
Evaluation of substrate specificity evolution across diverse herpesvirus kinases
Analysis of how kinase functions adapted to different host cellular environments
Assessment of how essential these kinases are for viral replication across different evolutionary lineages
The high conservation of viral kinases throughout herpesvirus evolution, as noted in the VZV studies, suggests these proteins serve fundamental roles in viral replication strategies across diverse hosts .